본문 바로가기
KERD
논문KCI 등재

우리나라 결핵 환자의 치료 장기화와 다약제내성결핵 발생에 영향을미치는 요인

Influential Factors to Prolonged Tuberculosis Treatment Duration and Multidrugresistant Tuberculosis Incidence

2

조회

0

다운로드

5

인용

0

참고문헌

키워드

초록

Objectives: Tuberculosis (TB) is a very important infectious disease in Korea. Among OECD countries, Korea has been had the highest rate in TB incidence, prevalence and death. In this study, we analyzed influencing factors to prolonged TB treatment and multidrug-resistant TB (MDR-TB) incidence. Methods: We collected 2007-2009 TB claim data in the National health insurance data. TB patients who diagnosed TB for the fist time in 2008 were selected. Variables like gender, age, grade of insurance premium, length of stay in inpatient service, number of visits in outpatient services, type of employment, and size of residential of the patients were included to analyse. The prolonged TB treatment duration was defined as more than 9 months for TB treatment. MDR-TB incidence was defined as U88.0 or U88.1 in KCD-5. Provit model was used to find influencing factors to prolonged TB treatment and MDR-TB incidence. And marginal effects were calculated to analyse the influencing intensity of variables. Results: 42,347 patients diagnosed and treated TB in 2008. 14,317 patients (33.8%) took treatment more than 9 months. The risk of prolonged TB treatment duration were increased significantly in male (0.6%), young (<20, 14.7%) or old (≥75, 6.0%) age groups, and lower income groups (5.9%-2.5%). The risk of MDR-TB incidence were increased in lower income groups. Conclusions: Age and income level influenced th prolonged TB treatment and MDR-TB incidence risk. More effective TB managements have to be developed for young (<20) or old (≥75) age group, and low income groups.

Abstract

Objectives: Tuberculosis (TB) is a very important infectious disease in Korea. Among OECD countries, Korea has been had the highest rate in TB incidence, prevalence and death. In this study, we analyzed influencing factors to prolonged TB treatment and multidrug-resistant TB (MDR-TB) incidence. Methods: We collected 2007-2009 TB claim data in the National health insurance data. TB patients who diagnosed TB for the fist time in 2008 were selected. Variables like gender, age, grade of insurance premium, length of stay in inpatient service, number of visits in outpatient services, type of employment, and size of residential of the patients were included to analyse. The prolonged TB treatment duration was defined as more than 9 months for TB treatment. MDR-TB incidence was defined as U88.0 or U88.1 in KCD-5. Provit model was used to find influencing factors to prolonged TB treatment and MDR-TB incidence. And marginal effects were calculated to analyse the influencing intensity of variables. Results: 42,347 patients diagnosed and treated TB in 2008. 14,317 patients (33.8%) took treatment more than 9 months. The risk of prolonged TB treatment duration were increased significantly in male (0.6%), young (<20, 14.7%) or old (≥75, 6.0%) age groups, and lower income groups (5.9%-2.5%). The risk of MDR-TB incidence were increased in lower income groups. Conclusions: Age and income level influenced th prolonged TB treatment and MDR-TB incidence risk. More effective TB managements have to be developed for young (<20) or old (≥75) age group, and low income groups.

참고문헌 (26)

  1. Sia IG, "Current concepts in the management of tuberculosis", Mayo Clin Proc, 86(4), pp.348~361 (2011)[DOI]
  2. "Global tuberculosis report 2015" (2015)[URL]
  3. "Improved data reveals higher global burden of tuberculosis"[URL]
  4. Park WS, "Notified tuberculosis status in Korea, 2015", KCDC (Korea Centers for Disease Control and Prevention), 9(19), pp.342~345 (2016)
  5. Comprehensive plan for national tuberculosis management, primary stage (2013-2017), "Cho SH", Ministry of Health and Welfare, ~ (2012)
  6. Korea Centers for Disease Control and Prevention, "Joint committee for the revision of Korean guidelines for tuberculosis. (2nd)", Korea Centers for Disease Control and Prevention, 90~92 (2014)
  7. World Health Organization, "Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis", World Health Organization, 91~92 (2014)
  8. 심태선, "다제내성결핵의 진단과 치료", 대한내과학회지, 88(5), pp.509~517 (2015), 대한내과학회[DOI]
  9. 이화선, "결핵환자의 재입원에 미치는 융복합적 영향요인", 디지털융복합연구, 13(5), pp.259~267 (2015), 한국디지털정책학회[DOI]
  10. 강영애, "다제내성 결핵의 진단과 치료", 대한의사협회지, 57(1), pp.27~33 (2014), 대한의사협회[DOI]
  11. 윤경일, "결핵 입원환자의 치료결과에 영향을 미치는 환자 특성과 의료기관 특성", 병원경영학회지, 19(2), pp.44~54 (2014), 한국병원경영학회
  12. 강석진, "청소년 폐결핵의 임상적 및 영상학적 특징: 재활동성 결핵과의 관련성", Allergy Asthma & Respiratory Diseases, 22(2), pp.163~170 (2012), 대한 소아알레르기 호흡기학회[DOI]
  13. Yoon-Sung Park, "The National Status of Tuberculosis Using Nationwide Medical Records Survey of Patients with Tuberculosis in Korea", Tuberculosis and Respiratory Diseases, 73(1), pp.48~55 (2012), 대한결핵및호흡기학회[DOI]
  14. Cho SH, "Tuberculosis outbreaks in Korea: 2005-2009", Public Health Weekly Rep, 4(8), pp.665~672 (2011)
  15. "Maximum Likelihood Estimation"[URL]
  16. Kim GR, "Analysis of suicidal ideation pathways and marginal effects in school bullying victims", Health Welf Forum, 220, pp.81~101 (2016)
  17. "Notified tuberculosis status in Korea, 2008" (2008)[URL]
  18. Kaona FAD, "An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patient on TB treatment", BMC Public Health, 4, pp.68~ (2004)[DOI]
  19. Lertmaharit S, "Factors associates with compliance among tuberculosis patients in Thailand", J Med Assoc Thai, 88(4), pp.149~156 (2005)
  20. Naing NN, "Factors contributing poor compliance with anti-TB treatment among tuberculosis patients", Southeast Asian J Trop Med Public Health, 32(2), pp.369~382 (2001)
  21. Connolly LE, "Why is long-term therapy required to cure tuberculosis", PLoS Med, 4(3), pp.e120~ (2007)[DOI]
  22. Djibuti M, "Household income and poor treatment outcome among patients with tuberculosis in Georgia: a cohort study", BMC Public Health, 14, pp.88~ (2014)[DOI]
  23. Oren E, "Area-level socioeconomic disadvantage and severe pulmonary tuberculosis: U.S. 2000–2008", Public Health Rep, 128(2), pp.99~109 (2013)
  24. Oren E, "Neighborhood socioeconomic position and tuberculosis transmission: a retrospective cohort study", BMC Infec Dis, 14(227) (2014)[DOI]
  25. Lutge E, "Economic support to improve tuberculosis treatment outcomes in South Africa: a qualitative process evaluation of a cluster randomized controlled trial", Trials, 15, pp.236~ (2014)[DOI]
  26. Spence DPS, "Tuberculosis and poverty", BMJ, 307(25), pp.759~761 (1993)

관련 논문AI추천

이 간행물의 다른 논문 (11건)